A total of 41 patients with 90 severe open fractures [89 IIIb (98.9%) and 1 IIIc (1.1%)] were examined. The mean (±SD) age was 38±16 years, 75.6% (31 cases) were men, and the injuries were due to traffic accidents (28 cases, 68.3%), blunt trauma (9 cases, 22%), drifting-down injury (3 cases, 7.3%), and twist trauma (1 case, 2.4%). All the patients were followed up to a minimum of 1 year since the end of their clinical course. One patient, unfortunately, selected amputation 4 weeks after the primary surgery because of economic reasons. The description of the demographics and injury details are shown in Table 1. Injury details, including MESS, open fracture classification, AO fracture classification, device of stabilization, flap type, initial antibiotic timing, and the timing of flap, were analyzed.
Table 1. Demographics and Clinical Details of the patients
Age(yrs)
|
Gender△
|
MESS score
|
Gustilo classification
|
AO classification
|
Fixation*
|
Flap#
|
Initial antibiotic timing
(hrs)
|
Flap timing
(hrs)
|
Secondary procedures&
|
Union (wks)
|
20
|
F
|
6
|
IIIB
|
42B3(b), 4F2A(b)
|
EF
|
ALT
|
12
|
18
|
|
45
|
54
|
M
|
10
|
IIIB
|
43C3.3, 4F2B(b),44B3.3
|
ORIF
|
ALT
|
8
|
14
|
Plate replacement 6 wks
|
52
|
42
|
F
|
7
|
IIIB
|
13C3.3, 2U1B1
|
ORIF
|
ALT
|
24
|
35
|
Skin graft 6 wks
|
43
|
34
|
M
|
7
|
IIIB
|
43A3.2, 4F3A
|
EF
|
ALT
|
9
|
18
|
|
15
|
31
|
M
|
8
|
IIIB
|
42C3(j), 4F2B(b)
|
ORIF + Screw
|
ALT
|
13
|
56
|
EF 6 wks
|
84
|
44
|
M
|
6
|
IIIB
|
2R3A3.1, 2U3A2.3, 77.2.1A, 77.3.1A
|
ORIF
|
ALT
|
4
|
18
|
|
29
|
9
|
F
|
6
|
IIIB
|
43A1.2, 4F2A(c), 87.1.3C
|
EF + Screw
|
ALT
|
22
|
37
|
|
16
|
47
|
M
|
10
|
IIIB
|
42B2(b), 4F2A(b)
|
EF + Screw
|
GAS
|
6
|
16
|
|
35
|
51
|
F
|
11
|
IIIB
|
42B3(a), 4F1B(n)
|
EF
|
GAS
|
20
|
30
|
Skin graft 6 wks
|
35
|
62
|
F
|
10
|
IIIB
|
42B3(a), 4F2A(a)
|
EF
|
GAS
|
12
|
18
|
|
39
|
59
|
M
|
11
|
IIIB
|
42C3(i), 4F2A(b)
|
EF
|
SOL
|
14
|
20
|
Bone graft + plate replacement + flap 19 wks
|
40
|
32
|
M
|
11
|
IIIB
|
42C2(j), 4F3A
|
EF + Screw
|
ALT
|
11
|
24
|
Flap 12 days
|
70
|
45
|
M
|
6
|
IIIB
|
42B2(a), 4F2A(a)
|
EF + Screw
|
GAS
|
6
|
16
|
|
36
|
41
|
M
|
11
|
IIIC
|
2R2C3(j), 2U2C3(j)
|
EF
|
ALT
|
4
|
16
|
Bone shortening + plate 26 wks
|
52
|
24
|
M
|
8
|
IIIB
|
42B2(c), 4F2A(c)
|
EF
|
ALT
|
12
|
50
|
Plate 9 days
|
38
|
41
|
M
|
7
|
IIIB
|
42C3(j), 4F2B(a)
|
EF
|
SOL
|
14
|
21
|
|
30
|
42
|
M
|
7
|
IIIB
|
42C3(j), 4F2A(b)
|
EF
|
SOL
|
3
|
12
|
Plate 8 wks
|
32
|
8
|
F
|
6
|
IIIB
|
42C2(j), 4F2B(b)
|
EF + Screw
|
ALT
|
24
|
39
|
Plate 6 wks
|
18
|
39
|
F
|
10
|
IIIB
|
42C3(j), 4F2B(b)
|
EF + Screw + Bone shortening
|
F-T ALT + ALT
|
26
|
29
|
Bone lengthening 35 wks
|
62
|
17
|
F
|
9
|
IIIB
|
2U2A2(b)
|
EF + ORIF
|
ALT
|
8
|
20
|
|
12
|
32
|
F
|
7
|
IIIB
|
43B1.1
|
EF
|
ALT
|
13
|
21
|
|
12
|
22
|
M
|
9
|
IIIB
|
42A2(a)
|
EF
|
GAS
|
13
|
20
|
Flap 4 wks
|
12
|
37
|
M
|
7
|
IIIB
|
42A3(b), 87.1.1B
|
EF + Screw
|
SOL
|
18
|
27
|
|
32
|
44
|
M
|
9
|
IIIB
|
42B2(c), 4F3B
|
EF + ORIF + Cement
|
F-T ALT
|
18
|
22
|
Bone graft + plate replacement 8 wks
|
22
|
54
|
M
|
11
|
IIIB
|
42C3(k), 4F3B, 81.1.B2, 82A2
|
EF + ORIF + Screw
|
ALT
|
20
|
33
|
Bone graft 7 wks
|
55
|
50
|
M
|
10
|
IIIB
|
42C2(i), 42A2(b), 4F1A(n), 4F2A(b)
|
EF + ORIF+ Screw
|
GAS
|
20
|
31
|
Skin graft 4 wks
|
36
|
65
|
M
|
8
|
IIIB
|
42B2(c), 4F2A(b)
|
EF + ORIF + Screw
|
SOL
|
11
|
19
|
UTN + bone graft 21wks
|
47
|
9
|
F
|
6
|
IIIB
|
42B2(b)
|
EF + ORIF
|
SOL
|
12
|
17
|
Bone graft + plate replacement 29 wks
|
42
|
43
|
M
|
9
|
IIIB
|
42C3(i), 4F2A(a), 87.1.1B, 87.3.2A
|
EF + ORIF + Screw
|
SOL
|
30
|
42
|
Amputation
|
-
|
46
|
M
|
7
|
IIIB
|
42C3(j), 4F2B(b)
|
EF + ORIF + Screw
|
SOL
|
18
|
26
|
Bone graft + plate replacement 11 wks
|
30
|
33
|
M
|
7
|
IIIB
|
42C2(j), 4F2A(b)
|
EF + Screw
|
ALT
|
11
|
21
|
Bone graft + plate replacement 7 wks
|
23
|
27
|
M
|
6
|
IIIB
|
41B3.1, 42C3(j), 4F2A(a)
|
EF + ORIF + Cement
|
ALT
|
12
|
28
|
Bone graft + plate replacement 17 wks
|
30
|
24
|
M
|
4
|
IIIB
|
42C3(j), 4F2A(b)
|
EF + ORIF + Cement
|
GAS
|
23
|
31
|
Bone graft + plate replacement 17 wks
|
29
|
30
|
M
|
8
|
IIIB
|
42C3(j), 4F2B(b)
|
EF + ORIF + Cement+ Bone shortening
|
GAS
|
14
|
27
|
Bone graft + plate replacement 10 wks
|
18
|
42
|
M
|
7
|
IIIB
|
42C2(j), 4F2B(b)
|
EF + ORIF + Cement
|
SOL
|
15
|
25
|
Bone graft + plate replacement 7 wks
|
21
|
77
|
M
|
9
|
IIIB
|
32B3(c), 42B3(b)
|
ORIF + Screw + Cement
|
GAS
|
6
|
18
|
Skin graft 2 wks
|
50
|
27
|
M
|
6
|
IIIB
|
42C3(j), 4F2A(b)
|
EF + ORIF + Cement
|
SOL
|
9
|
17
|
Bone graft + plate replacement 7 wks
|
19
|
20
|
M
|
6
|
IIIB
|
41C3.3, 4F2A(a)
|
EF + ORIF + Screw + Cement
|
GAS
|
11
|
19
|
|
23
|
65
|
M
|
8
|
IIIB
|
42C3(j), 4F2A(b)
|
EF + ORIF + Cement
|
SOL
|
25
|
38
|
Bone graft + plate replacement 8 wks
|
32
|
37
|
M
|
9
|
IIIB
|
43A2.1, 44B3.1
|
EF + ORIF + Screw
|
ALT
|
7
|
41
|
Skin graft 3 wks
|
33
|
39
|
M
|
7
|
IIIB
|
41C3.1, 42C3(j), 4F2A(a)
|
EF + ORIF + Screw + Cement
|
SOL
|
20
|
33
|
Bone graft + plate replacement 18 wks
|
32
|
△F, female; M, male
* EF, external fixation; ORIF, plating; Cement, bone cement
# ALT, anterolateral thigh flap; GAS, gastrocnemius; SOL, soleus
& UTN, unreamed tibial nial
Fixation Table 2 exhibits the kind of fixation device chosen for different patients and associated results. 9 options were chosen for different fractures and 7 of them were applied in a multiple fixation devices combinational way rather than used solely.
Table 2. Details of the results according to the fixation device used
Fixation device
|
Number
|
Amputation
|
Union time
(median, IQR, wks)
|
Acute-Flap infection
|
Chronic-Fracture site infection
|
EF
|
11
|
|
35(15 to 40)
|
|
1
|
ORIF
|
3
|
|
43(29 to 52)
|
|
1
|
EF + ORIF
|
2
|
|
27(12, 42)
|
|
|
EF + Screw
|
8
|
|
33.5(19.25 to 55.5)
|
|
1
|
ORIF + Screw
|
1
|
|
84
|
1
|
|
EF + ORIF + Screw
|
6
|
1
|
36(31.5 to 51)
|
|
1
|
ORIF + Screw + Cement
|
1
|
|
50
|
|
1
|
EF + ORIF + Cement
|
7
|
|
22(19 to 30)
|
|
|
EF + ORIF + Screw + Cement
|
2
|
|
27.5(23, 32)
|
|
|
Soft tissue reconstruction
The soft tissue cover was accomplished by two kinds of local transfer flaps (10 gastrocnemius and 12 soleus) and free anterolateral thigh flap (19 cases) according to the characteristic of injury (Tables 1 and 5). All flaps survived in all patients uneventfully and showed better appearance, color, and texture as well as satisfactory sensation. More significantly, the soft tissue cover was achieved within 72 h in all 41 patients, and the median (IQR) time was 22 (18–32) h. Furthermore, 22 cases were covered immediately (≤24 h, while the remaining as early as possible (24–60 h). The associated results between immediate and early coverage are shown in Table 3.
Table 3. Details of the results related to the timing of soft-tissue cover
Timing of cover (hr)
|
Number
|
Amputation
|
Union time (median, IQR, wks)
|
Flap
infection
|
Deep
infection
|
Immediate(≤24)
|
22
|
0
|
33.5(21.25 to 45.5)
|
0
|
4 (18%)
|
Early(24-60 )
|
19
|
1
|
32(27 to 39.25)
|
1 (5%)
|
1 (5%)
|
Infection
The overall rate of infection was 14.6%(6/41), which included one acute flap infection and five chronic fracture site infection. The rate of infection was 28.6% (4/14) in the first 6 years (September 2008 to July 2014), and 7.4% (2/27) in the next 5 years (August 2014 to April 2019). These problems were resolved by antibiotics and repeated debridement. The distribution details of infection based on age, sex, MESS score, time of coverage, initial antibiotic timing, and characteristics of the injury are shown in Tables 4 and 5. Six infected fractures were found in men with a high MESS score (>7). A comparison of the infected and noninfected fractures in Table 4 shows that males were associated with an increased rate of infection (P < 0.001). The same results were obtained for the increased MESS score (P = 0.021). However, no significant difference was found in age, time of coverage, and initial antibiotic timing between the infected and noninfected fractures.
Table 4. Factors associated with infection. Statistically significant analyses are highlighted in bold
Variable
|
Non-infected fractures(n=35)(%)
|
Infected
fractures(n=6)(%)
|
p-value
|
Mean age (yrs) (range)
|
36 (8 to 65)
|
48 (31 to 77)
|
0.093
|
Male gender
|
25 (71.4)
|
6 (100)
|
0.0001
|
MESS>7
|
15 (42.9)
|
6 (100)
|
0.021
|
Lower limb fracture
|
32 (91.4)
|
5 (83.3)
|
0.483
|
Median time to first coverage (hrs) (IQR)
|
22 (18 to 31)
|
21 (15.5 to 38.75)
|
0.592
|
Immediate coverage (≤24)
|
18 (51.4)
|
4 (66.7)
|
0.668
|
Initial antibiotic timing (hrs) (range)
|
14.7 (3 to 30)
|
10.3 (4 to 20)
|
0.139
|
Table 5. Characteristics of the soft tissue injury and coverage
Characteristic
|
Number
|
Infection (%)
|
Main injured zone
|
|
|
Elbow joint
|
1
|
|
Middle forearm
|
2
|
1 (50%)
|
Forearm to hand
|
1
|
|
Proximal leg
|
3
|
|
Middle leg
|
26
|
3 (11.5%)
|
Distal leg
|
2
|
|
Distal leg to ankle/foot
|
6
|
2 (33.3%)
|
Soft tissue defect location
|
|
|
Anterior
|
5
|
2 (40%)
|
Interior
|
4
|
1 (25%)
|
Anteromedial
|
15
|
1 (6.7%)
|
Anterolateral
|
4
|
2 (50%)
|
Posterior
|
1
|
|
Posterolateral
|
1
|
|
Extensive
|
11
|
|
Flap
|
|
|
ALT
|
19
|
5 (26.3%)
|
GAS
|
10
|
1 (10%)
|
SOL
|
12
|
|
The rate of main injured zone infection at the site of the middle forearm, middle leg, and distal leg to ankle/foot was 50% (1/2), 11.5% (3/26), and 33.3% (2/6), respectively. For soft tissue defect location, the infection rate was 40% (2/5) anteriorly, 25% (1/4) interiorly, 6.7% (1/15) anteromedially, and 50% (2/4) anterolaterally. Besides, the rate of infection was 26.3% (5/19) in the free anterolateral thigh flap group and 10% (1/10) in the gastrocnemius flap group. Nevertheless, the number in each group was too small to identify a significant difference.
Bone healing
The median union time of all 40 patients was 32 weeks (IQR, 22.25–42.75). The union time in the nine fixation device groups is shown in Table 3. The median union time in the group with immediate placement of the cover was 33.5 weeks (IQR, 21.25–45.5). However, the median union time in the group with early placement of the cover was 32 weeks (IQR, 27–39.25). The difference in union time between the two groups was not statistically significant (P = 0.87).